HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer.

Abstract
Targeted delivery system would be an interesting platform to enhance the therapeutic effect and to reduce the side effects of anticancer drugs. In this study, we have developed lactobionic acid (LA)-modified chitosan-stearic acid (CS-SA) (CSS-LA) to deliver doxorubicin (DOX) to hepatic cancer cells. The average particle size of CSS-LA/DOX was ∼100 nm with a high entrapment efficiency of >95%. Drug release studies showed that DOX release from pH-sensitive micelles is significantly faster at pH 5.0 than at pH 7.4. The LA conjugated micelles showed enhanced cellular uptake in HepG2 and BEL-7402 liver cancer cells than free drug and unconjugated micelles. Consistently, CSS-LA/DOX showed enhanced cell cytotoxicity in these two cell lines. Annexin-V/FITC and PI based apoptosis assay showed that the number of living cells greatly reduced in this group with marked presence of necrotic and apoptotic cells. LA-conjugated carrier induced typical chromatic condensation of cells; membrane blebbing and apoptotic bodies began to appear. In vivo, CSS-LA/DOX showed an excellent tumor regression profile with no toxic side effects. The active targeting moiety, long circulation profile, and EPR effect contributed to its superior anticancer effect in HepG2 based tumor. Our results showed that polymeric micelles conjugated with LA increased the therapeutic availability of DOX in the liver cancer cell based solid tumor without any toxic side effects. The active targeting ligand conjugated nanoparticulate system could be a promising therapeutic strategy in the treatment of hepatic cancers.
AuthorsYuan Yang, Sheng-Xian Yuan, Ling-Hao Zhao, Chao Wang, Jun-Sheng Ni, Zhen-Guang Wang, Chuan Lin, Meng-Chao Wu, Wei-Ping Zhou
JournalMolecular pharmaceutics (Mol Pharm) Vol. 12 Issue 2 Pg. 644-52 (Feb 02 2015) ISSN: 1543-8392 [Electronic] United States
PMID25495890 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Disaccharides
  • Drug Carriers
  • Micelles
  • Polymers
  • Stearic Acids
  • stearic acid
  • lactobionic acid
  • Doxorubicin
  • Chitosan
Topics
  • Animals
  • Apoptosis (drug effects)
  • Cell Line, Tumor
  • Chitosan (chemistry)
  • Disaccharides (chemistry)
  • Doxorubicin (administration & dosage, chemistry, therapeutic use)
  • Drug Carriers (chemistry)
  • Drug Delivery Systems (methods)
  • Hep G2 Cells
  • Humans
  • Liver Neoplasms (drug therapy)
  • Mice, Nude
  • Micelles
  • Polymers (chemistry)
  • Stearic Acids (chemistry)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: